H.R. 2541
IntroducedNuclear Medicine Clarification Act of 2025
Plain-language analysis
Not yet analyzed.
A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text below and the official source are the record.
Full text of the bill
Official source on Congress.gov ↗[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 2541 Introduced in House (IH)]
<DOC>
119th CONGRESS 1st Session H. R. 2541
To require the Nuclear Regulatory Commission to revise its regulations to protect patients from unintended exposure to radiation during nuclear medicine procedures, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
April 1, 2025
Mr. Davis of North Carolina (for himself, Mr. Griffith, and Mr. Cline) introduced the following bill; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To require the Nuclear Regulatory Commission to revise its regulations to protect patients from unintended exposure to radiation during nuclear medicine procedures, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Nuclear Medicine Clarification Act of 2025''.
SEC. 2. MEDICAL EVENT REPORTING OF UNINTENDED IRRADIATION.
(a) Revision of Regulations Required.--Not later than 120 days after the date of enactment of this Act, the Nuclear Regulatory Commission shall revise section 35.3045(a)(1) of title 10, Code of Federal Regulations, by adding at the end the following: ``(iv) A dose that is due to an extravasation and exceeds--
``(A) 0.5 Sv (50 rem) dose equivalent to the 5 cubic centimeter volume of tissue receiving the highest absorbed dose during residence time; or
``(B) 0.5 Sv (50 rem) shallow dose equivalent to the contiguous 10 square centimeters of skin receiving the highest absorbed dose during residence time.''.
(b) Effective Date.--The revision required under subsection (a) shall take effect on the date that is 18 months after the date of enactment of this Act. <all>